Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OTC labeling rule

This article was originally published in The Tan Sheet

Executive Summary

Hours per response and total hours spent responding to "Drug Facts" labeling requirements "may be less than the numbers stated" in March 1999 OTC labeling final reg, agency says in Feb. 26 Federal Register notice. Although final rule estimated 2.5 to 4 hours per response per product, agency notes "respondents have made a number of inquiries since the final rule" was issued, with inquiries generally averaging .25 to .5 hours each. In addition, February 2001 draft guidance that provided ANDA labeling examples "should have reduced some of the hours per response and total hours for some NDA and ANDA holders," agency notes. Nevertheless, FDA says it is not "currently able to estimate how much the time has been reduced"...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093701

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel